Search Results 1651-1660 of 18452 for Immunode
History of clinically significant immunosuppressive disorder, autoimmune/autoinflammatory disorder, primary or secondary immunodeficiency, or disorder with ...
Known uncontrolled human immunodeficiency virus (HIV) infection. Severe bacterial, fungal, viral, and/or parasitic infections under treatment with ...
Known human immunodeficiency virus (HIV)-positive individuals are ineligible; Patients may not use any complementary or alternative medicines including ...
Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible as long ...
Negative human immunodeficiency virus (HIV), hepatitis B and C, and tuberculosis (TB) test. Provide written informed consent. Willing to return to the ...
Active hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) at screening. Had or has a clinically significant psychiatric disorder, including the ...
History of opportunistic infection or immunodeficiency syndrome. Currently on any chronic systemic (oral or intravenous) anti-infective therapy for chronic ...
Patients who are human immunodeficiency virus (HIV)-positive are eligible if: CD4+ cell count greater or equal to 250 cells/mm^3; If patient is on ...
Valganciclovir is used to treat symptoms of cytomegalovirus (CMV) retinitis, an infection in the eyes of people with acquired immunodeficiency syndrome (AIDS).
Known active human immunodeficiency virus (HIV) infection (defined as patients who are not on anti-retroviral treatment and have detectable viral load and CD4+ ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.